Maersk meets increased customer needs with a dedicated, carbon neutral Pharma warehouse in Poland

To further increase its capabilities in serving pharmaceutical customers in Central Europe, Maersk is launching its second dedicated warehouse in Poland, specifically designed for this customer segment and with carbon neutrality in mind.

Mszczonow, Poland --- Since 2001, Maersk has been offering global pharmaceutical players in Central Europe professional warehousing and distribution services specifically tailored to meet the needs of this demanding customer segment. To further build on this experience and address growing customer needs, Maersk is launching a project to create a second pharmaceutical warehouse as part of its existing warehousing and distribution centre in Mszczonow (Poland), expected to be operational by end of June 2021.

Focus on quality and sustainable solutions

Equipped with a modern, state-of-the-art temperature controlling system that will ensure the safety of sensitive cargo, the new building will be to a large extent powered by renewable energy, ensuring its sustainability and carbon neutrality. The facility will have integrated Quality Management System implemented, based on Good Distribution and Manufacturing Practice (GDP) and ISO certificates.

The warehouse will be an addition to Maersk’s already existing own warehousing and distribution centre in Mszczonow (Poland), which has dedicated sections for human and animal health products and will be operated by a staff of experts in logistics needs of this customer group.

“In such an industry, quality plays a pivotal role and it can only be guaranteed by experienced and competent personnel who have a thorough understanding of specific requirements of pharmaceutical customers”, shares Jakub Mach, Ph.D., Country Cold Chain Logistics Manager at Maersk in Poland. “In that sense, the new project is equally important for the additional warehousing space we will bring to the market, as it is for the capabilities of our people involved in daily operations”.

The new warehousing and distribution centre will in addition offer repacking capabilities, as well as professional transportation services in different temperature ranges (ambient, cold, liquid nitrogen and dry ice) based on a validated Transport Management System.

Preparing for future growth

“Our ambition is to be top choice healthcare logistics provider and No. 1 in Animal Health logistics by offering high quality solutions for the healthcare industry, as well as flexibility in adapting to its specific requirements”, shares Hristo Petkov, Global Vertical Head, Pharma at Maersk. “The pharmaceutical industry is experiencing growth, which we can support with even more warehousing and distribution capacity, coupled with market knowledge and capabilities of our dedicated teams.”

FACT BOX – new Maersk pharmaceutical warehouse in Mszczonow, Poland

Fully compliant with EU GDP (Good Distribution Practice) (2013/C 343/01), GMP, ISO 9001 [QMS], ISO 13485 [Medical Devices], ISO 22000 [HACCP]

Modern, carbon neutral facility thanks to photovoltaic energy solutions installed, which provide a total of ca. 600 MWh annually

Available space: ca. 15 000 sqm; operational height: 11,5 m; approximate capacity: ca. 24 000 pallet places

Strategic location:

• 40 km from Warsaw Chopin Airport
• Next to S7 motorway, connecting two most populous Polish metropolitan areas – Silesia and Mazovia with Warsaw
• Easy access to A1 and A2 – two major Polish highways, linking North with South and East with West
• Road bypassing the town allows to reduce traffic jams in the proximity of Logistics Park

About Maersk

A.P. Moller - Maersk is an integrated container logistics company working to connect and simplify its customers’ supply chains. As the global leader in shipping services, we operate in 130 countries and employ roughly 76,000 people. Our mission is to enable and facilitate global supply chains and provide opportunities for our customers to trade globally.